(Q34739424)

4 August 2017

title

Concentration of debrisoquine by human platelets in vivo: relationship to hypotensive effect [proceedings] (English)

1 reference

4 August 2017

M. S. Lennard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A911620

6 August 2022

J. H. Silas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A911620

6 August 2022

A. J. Smith

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A911620

6 August 2022

G. T. Tucker

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A911620

6 August 2022

language of work or name

English

0 references

publication date

1 October 1977

1 reference

British Journal of Clinical Pharmacology

4 August 2017

published in

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

635P

1 reference

Determination of debrisoquin and its 4-hydroxy metabolite in plasma by gas chromatography/mass spectrometry

4 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1977.TB00807.X

Why hypertensive patients vary in their response to oral debrisoquine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1977.TB00807.X

10.1111/J.1365-2125.1977.TB00807.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference